{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:28:13Z","timestamp":1792099693440,"version":"4.4.0"},"reference-count":22,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Genet"],"published-print":{"date-parts":[[1996,2]]},"abstract":"<jats:p>A genetic register for von Hippel-Lindau disease was set up in the north west of England in 1990. Population statistics, clinical features, age at onset, and survival of 83 people affected with von Hippel-Lindau (VHL) disease were studied. In addition, the effectiveness of the screening programme used and the occurrence of central nervous system haemangioblastomas in the general population were examined. The diagnostic point prevalence of heterozygotes in the North Western Region was 1 center dot 18\/100 000 (1\/85 000) people, with an estimated birth incidence of 2 center dot 20\/100 000 (1\/45 500) live births. The mutation rate was estimated directly to be 1 center dot 4 x 10(-6)\/gene\/generation (1\/714 200). The mean age at onset of first symptoms was 26 center dot 25 years, with cerebellar haemangioblastoma being the most common presenting manifestation (34 center dot 9% of cases). The mean age at diagnosis of VHL disease was 30 center dot 87 years. Overall, 50 patients (60 center dot 2%) developed a cerebellar haemangioblastoma, 34 (41 center dot 0%) a retinal angioma, 21 (25 center dot 3%) a renal cell carcinoma, 12 (14 center dot 5%) a spinal haemangioblastoma, and 12 (14 center dot 5%) a phaeochromocytoma. Mean age at diagnosis of renal cell carcinoma (38 center dot 9 years) was significantly higher than that for cerebellar haemangioblastoma (30 center dot 0 years) and retinal angioma (21.1 years). Mean age at death was 40 center dot 9 years with cerebellar haemangioblastoma being the most common cause (47 center dot 7% of deaths). A total of 65 VHL manifestations were diagnosed asymptomatically following appropriate clinical and radiological screening tests, and failure to detect manifestations of VHL disease in spite of appropriate screening occurred on only two occasions. The use of DNA linkage analysis and direct mutation testing reduced the personal risk of carrying the VHL gene to below 1% in 14 people. In addition to the 83 clinically affected subjects, three obligate carriers who were considered to be lesion free in spite of extensive screening tests were identified. Fourteen percent of all CNS haemangioblastomas on the regionally based Cancer Registry were found to occur as part of VHL disease, but investigations for VHL in apparently sporadic disease appeared to be limited.<\/jats:p>","DOI":"10.1136\/jmg.33.2.120","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T15:37:21Z","timestamp":1226331441000},"page":"120-127","source":"Crossref","is-referenced-by-count":199,"title":["A genetic register for von Hippel-Lindau disease."],"prefix":"10.1136","volume":"33","author":[{"given":"I R","family":"Maddock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E R","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Teare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Whitehouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Super","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1996,2,1]]},"reference":[{"key":"ref_1","first-page":"595","article-title":"Lindau's disease. Review of the literature and study of a large kindred","volume":"36","author":"Melmon, K.L.; Rosen, S.W.","year":"1964","unstructured":"Melmon KL, Rosen SW. Lindau's disease. Review of the literature and study of a large kindred. Am 7 Med 1964; 36:595-617.","journal-title":"Am 7 Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-198901000-00001","article-title":"Von Hippel-Lindau disease affecting 43 members of a single kindred","volume":"68","author":"Lamiell, J.M.; Salazar, F.G.; Hsia, Y.E.","year":"1989","unstructured":"Lamiell JM, Salazar FG, Hsia YE. Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 1989;68: 1-29.","journal-title":"Medicine (Baltimore)"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease","volume":"77","author":"Maher, E.R.; Yates, J.R.W.; Harries, R.","year":"1990","unstructured":"Maher ER, Yates JRW, Harries R, et al. Clinical features and natural history of von Hippel-Lindau disease. Q _7 Med 1990;77:1151-63.","journal-title":"Q _7 Med"},{"key":"ref_4","first-page":"743","article-title":"Von Hippel-Lindau disease","volume":"76","author":"Maher, E.R.; Moore, A.T.","year":"1992","unstructured":"Maher ER, Moore AT. Von Hippel-Lindau disease. Br 7 Ophthalmol 1992;76:743-5."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/332268a0","article-title":"Von HippelLindau disease maps to the region of chromosome 3 associated with renal cell carcinoma","volume":"332","author":"Seizinger, B.R.; Rouleau, G.A.; Ozelius, L.J.","year":"1988","unstructured":"Seizinger BR, Rouleau GA, Ozelius LJ, et al. Von HippelLindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 1988;332: 268-9.","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/jmg.29.12.902","article-title":"Presymptomatic diagnosis of von Hippel-Lindau disease with flanking DNA markers","volume":"29","author":"Maher, E.R.; Bentley, E.; Payne, S.J.","year":"1992","unstructured":"Maher ER, Bentley E, Payne SJ, et al. Presymptomatic diagnosis of von Hippel-Lindau disease with flanking DNA markers. _7 Med Genet 1992;29:902-5.","journal-title":"_7 Med Genet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/hmg\/2.3.279","article-title":"Genetic linkage between Von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus","volume":"2","author":"Crossey, P.A.; Maher, E.R.; Jones, M.H.","year":"1993","unstructured":"Crossey PA, Maher ER, Jones MH, et al. Genetic linkage between Von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus. Hum Molec Genet 1993;2:279-82.","journal-title":"Hum Molec Genet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumour suppressor gene","volume":"260","author":"Latif, F.; Tory, K.; Gnarra, J.","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumour suppressor gene. Scienzce 1993;260:1317-20.","journal-title":"Scienzce"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/096914139400100205","article-title":"A rational approach to radiological screening in von Hippel-Lindau disease","volume":"1","author":"Harries, R.W.J.","year":"1994","unstructured":"Harries RWJ. A rational approach to radiological screening in von Hippel-Lindau disease. _7 Med Screening 1994;1: 88-95.","journal-title":"_7 Med Screening"},{"key":"ref_10","first-page":"233","article-title":"Von Hippel-Lindau disease in a large British family: clinicopathological features and recommendations for screening and follow-up","volume":"66","author":"true","year":"1988","unstructured":"Jennings AM, Smith C, Cole DR, et al. Von Hippel-Lindau disease in a large British family: clinicopathological features and recommendations for screening and follow-up. Q _7 Med 1988;66:233-49."},{"key":"ref_11","first-page":"545","article-title":"Von Hippel-Lindau disease: a genetic condition predisposing tumour formation","volume":"18","author":"Martz, C.H.","year":"1991","unstructured":"Martz CH. Von Hippel-Lindau disease: a genetic condition predisposing tumour formation. Oncology Nursing Forum 1991;18:545-51.","journal-title":"Oncology Nursing Forum"},{"key":"ref_12","first-page":"1689","article-title":"A regional register for inherited cancers","volume":"298","author":"Littler, M.; Harper, P.S.","year":"1989","unstructured":"Littler M, Harper PS. A regional register for inherited cancers. BMA7 1989;298:1689-91."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/brain\/109.6.1297","article-title":"Cerebellar haemangioblastoma and von Hippel-Lindau disease","volume":"109","author":"Huson, S.M.; Harper, P.S.; Hourihan, M.D.; Cole, G.; Weeks, R.D.; Compston, D.A.S.","year":"1986","unstructured":"Huson SM, Harper PS, Hourihan MD, Cole G, Weeks RD, Compston DAS. Cerebellar haemangioblastoma and von Hippel-Lindau disease. Brain 1986;109: 1297-310.","journal-title":"Brain"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0022-510X(90)90008-B","article-title":"Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis","volume":"100","author":"Maher, E.R.; Bentley, E.; Yates, J.R.W.","year":"1990","unstructured":"Maher ER, Bentley E, Yates JRW, et al. Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis. _7 Neurol Sci 1990;100:27-30.","journal-title":"_7 Neurol Sci"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/hmg\/3.4.595","article-title":"Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene","volume":"3","author":"Richards, F.M.; Crossey, P.A.; Phipps, M.E.","year":"1994","unstructured":"Richards FM, Crossey PA, Phipps ME, et al. Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Hum Molec Genet 1994; 3:595-8.","journal-title":"Hum Molec Genet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/3.8.1303","article-title":"Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype","volume":"3","author":"Crossey, P.A.; Richards, F.M.; Foster, K.","year":"1994","unstructured":"Crossey PA, Richards FM, Foster K, et al. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Molec Genet 1994;3:1303-8.","journal-title":"Hum Molec Genet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","article-title":"Von Hippel-Lindau disease: a genetic study","volume":"28","author":"Maher, E.R.; Iselius, L.; Yates, J.R.W.","year":"1991","unstructured":"Maher ER, Iselius L, Yates JRW, et al. Von Hippel-Lindau disease: a genetic study. 7 Med Genet 1991;28:443-7.","journal-title":"7 Med Genet"},{"key":"ref_18","article-title":"Population Censuses and Surveys","author":"Office of","year":"1993","unstructured":"Office of Population Censuses and Surveys. Vital Statistics, 1993. London: HMSO, 1994.","journal-title":"Vital Statistics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(91)91705-Y","article-title":"Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus","volume":"337","author":"Neumann, H.P.H.; Wiestler, O.D.","year":"1991","unstructured":"Neumann HPH, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 1991;337:1052-4.","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.1976.03630070017007","article-title":"Von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members","volume":"136","author":"Horton, W.A.; Wong, V.; Eldridge, R.","year":"1976","unstructured":"Horton WA, Wong V, Eldridge R. Von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members. Arch Intern Med 1976;136: 769-77.","journal-title":"Arch Intern Med"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1399-0004.1994.tb04003.x","article-title":"Non-expression of von Hippel-Lindau phenotype in an obligate carrier","volume":"45","author":"Davies, D.R.; Norman, A.M.; Whitehouse, R.W.; Evans, D.G.R.","year":"1994","unstructured":"Davies DR, Norman AM, Whitehouse RW, Evans DGR. Non-expression of von Hippel-Lindau phenotype in an obligate carrier. Clin Genet 1994;45: 104-6.","journal-title":"Clin Genet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0009-9260(83)80238-4","article-title":"The incidence of simple renal cyst by computed tomography","volume":"34","author":"Tada, S.; Yamagishi, J.; Kobayashi, H.; Hata, Y.; Kobari, T.","year":"1983","unstructured":"Tada S, Yamagishi J, Kobayashi H, Hata Y, Kobari T. The incidence of simple renal cyst by computed tomography. Clin Radiol 1983;34:437-9.","journal-title":"Clin Radiol"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg.33.2.120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:52:31Z","timestamp":1759690351000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg.33.2.120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[1996,2,1]]},"published-print":{"date-parts":[[1996,2]]}},"alternative-id":["10.1136\/jmg.33.2.120"],"URL":"https:\/\/doi.org\/10.1136\/jmg.33.2.120","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,2]]}}}